Table 1.
Types of treatments available for Primary Immunodeficiencies (PID) patients in Southeast Asia (SEA).
| Types of treatment | Availability of treatment, N=6 (%) | |||
|---|---|---|---|---|
| No | Not regularly | Most of the time | Yes | |
| A) Biological treatments | ||||
| Enzymes | 0 | 0 | 0 | 6 (100.0) |
| Immunosuppressors | 1 (16.7) | 3 (50.0) | 1 (16.7) | 1 (16.7) |
| Monoclonal antibodies | 0 | 4 (66.7) | 1 (16.7) | 1 (16.7) |
| Cytokines | 3 (50.0) | 3 (50.0) | 0 | 0 |
| Growth Factor | 1 (16.7) | 2 (33.3) | 1 (16.7) | 2 (33.3) |
| C1 inhibitor | 5 (83.3) | 1 (16.7) | 0 | 0 |
| Thrombopoietin | 4 (66.7) | 1 (16.7) | 0 | 1 (16.7) |
| B) Routes of immunoglobulin | ||||
| IVIG | 0 | 1 (16.7) | - a | 5 (83.3) |
| SCIG | 3 (50.0) | 2 (33.3) | - a | 1 (16.7) |
| FSCIG | 4 (66.7) | 2 (33.3) | - a | 0 |
| C) Anti-infectious | ||||
| Antibiotics | 0 | 0 | 1 (16.7) | 5 (83.3) |
| Antivirals | 0 | 0 | 0 | 6 (100.0) |
| Antifungals | 0 | 2 (33.3) | 1 (16.7) | 3 (50.0) |
| Antiparasitic | 1 (16.7) | 1 (16.7) | 0 | 4 (66.7) |
| D) Vaccines | 1 (16.7) | - a | - a | 5 (83.3) |
| E) Curative treatments | ||||
| Bone marrow transplant | 2 (33.3) | - a | - a | 4 (66.7) |
| Gene therapy | 6 (100.0) | - a | - a | 0 |
| Thymic transplant | 6 (100.0) | - a | - a | 0 |
a
Not determined.
Descriptive analysis was used to compare the frequency of different PID treatment options in 6 SEA countries. The results were expressed in n (%), where n represented the number of countries.